Potential for Larger Gene Panels to Increase the Number of Molecularly Matched Therapies in Patients with Advanced Solid Tumours By Ogkologos - April 22, 2025 728 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ProfiLER-02 study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Picking out the sound of tumours June 18, 2020 Living With Metastatic Breast Cancer: How I Reinvented Myself October 30, 2020 To Improve Immunotherapy, Researchers Look at Limiting Cancer’s Access to Sugar... February 18, 2021 Niraparib Maintenance Significantly Reduces the Risk of Disease Progression or Death... July 31, 2023 Load more HOT NEWS Exercising Safely During Breast Cancer Treatment: What to Know How targeted screening can help the NHS save lives from lung... Trial Results Support SBRT as a Standard Option for Some Prostate... No OS Benefit from Continuous as Compared with Fixed-Duration Maintenance Therapy...
